Why this commencement speech was canceled (with Arcellx CEO Rami Elghandour) | Rapid Response

About Rami

• Led 2 IPOs; built 2 public biotechs into multibillion-dollar companies
  
• Engineered Arcellx's 2026 sale to Gilead for nearly $8B
  
• Scaled Arcellx to $6B+ peak valuation; Nevro to $3B+ market value
  
• Raised $1.75B+ to advance cancer and autoimmune therapies